Ahmad Bechara, PhD
Vice President, Global Market Access
Ahmad Bechara is the Vice President, Global Market Access at Alira Health. Prior to joining Alira Health, Ahmad was a Director at Wellmera with over fourteen years of experience in both the pharmaceutical industry and academic research.
He is responsible for a wide range of global pricing and market access deliverables across several therapeutic areas, including cardiometabolic, hematology, oncology and rare diseases. Ahmad provides strategic insights and recommendations on clinical trial design to maximize market access and reimbursement opportunities. He is involved in the development of global pricing and market access strategies, evidence gap analyses, and payer objection handling tools. Ahmad designs and facilitates product workshops and training for countries to help countries prepare for HTA submissions, payer negotiations, and communication on the value of their products. Additionally, Ahmad has developed for global teams ATC and DDD strategies and submission dossiers to the World Health Organization.
Previously, Ahmad worked at the Global Market Access Cardio-Metabolic franchise of Novartis Global (Basel, Switzerland) where he was involved in pre-launch and launch preparations of several assets. He managed market insight collection and digital tools for payer and KOL engagement and developed a business case for creating a new stock-keeping unit to reduce drug wastage.
Ahmad holds a Ph.D. in Genetics and Neuroscience from the University of Claude Bernard in Lyon, where he researched the molecular mechanisms of topographic brain map formation and plasticity. Ahmad has authored and co-authored several publications in the genetic and neuroscience fields.